A share price of Agios Pharmaceuticals Inc [AGIO] is currently trading at $49.03, up 5.24%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The AGIO shares have gain 7.66% over the last week, with a monthly amount glided 5.28%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Piper Sandler started tracking the stock with Overweight rating on February 03, 2023, and set its price target to $41. On November 17, 2022, upgrade upgraded it’s rating to Neutral and revised its price target to $32 on the stock. SVB Leerink upgraded its rating to a Outperform but stick to its price target of $33 on July 27, 2022. BofA Securities initiated its recommendation with a Buy and recommended $54 as its price target on December 03, 2021. Goldman downgraded its rating to Sell for this stock on July 30, 2021, and downed its price target to $39. In a note dated July 01, 2021, Raymond James initiated an Mkt Perform rating.
Agios Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $19.80 and $50.35. Currently, Wall Street analysts expect the stock to reach $47.5 within the next 12 months. Agios Pharmaceuticals Inc [NASDAQ: AGIO] shares were valued at $49.03 at the most recent close of the market. An investor can expect a potential drop of -3.12% based on the average AGIO price forecast.
Analyzing the AGIO fundamentals
Trailing Twelve Months sales for Agios Pharmaceuticals Inc [NASDAQ:AGIO] were 31.31M which represents 28.35% growth. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at -12.94%, Pretax Profit Margin comes in at -11.66%, and Net Profit Margin reading is -11.66%. To continue investigating profitability, this company’s Return on Assets is posted at -0.47, Equity is -0.47 and Total Capital is -0.57. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 46.68 points at the first support level, and at 44.33 for the second support level. However, for the 1st resistance point, the stock is sitting at 50.26, and for the 2nd resistance point, it is at 51.48.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Agios Pharmaceuticals Inc [NASDAQ:AGIO] is 10.09. In addition, the Quick Ratio stands at 9.71 and the Cash Ratio stands at 1.35. Considering the valuation of this stock, the price to sales ratio is 89.09, the price to book ratio is 4.22.
Transactions by insiders
Recent insider trading involved Goff Brian, Chief Executive Officer, that happened on Aug 08 ’24 when 11091.0 shares were sold. Officer, Goff Brian completed a deal on Aug 08 ’24 to buy 11091.0 shares. Meanwhile, Chief Medical Officer Gheuens Sarah sold 3705.0 shares on Jul 01 ’24.
